Every story we've covered involving longevity-biotech.
Investment into longevity biotechnology has surged as companies and researchers aim to treat the biological drivers of ageing to extend healthspan and lifespan. The field draws on discoveries such as the 'hallmarks of ageing,' advances in genetic and cellular manipulation, and recent biotech and AI-driven successes that have heightened investor enthusiasm.
No stories here yet.